Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 15, 2018
- Revision received April 3, 2019
- Accepted May 16, 2019
- Published first May 28, 2019.
Article Versions
- Previous version (May 28, 2019 - 08:33).
- You are currently viewing a Previous version of this article (June 18, 2019 - 07:40).
- View the most recent version of this article
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Katherine D. Crew1,*,
- Garnet L. Anderson2,
- Dawn L. Hershman1,
- Mary Beth Terry1,
- Parisa Tehranifar1,
- Danika L. Lew3,
- Monica Yee3,
- Eric A. Brown4,
- Sebastien S. Kairouz5,
- Nafisa Kuwajerwala4,
- Therese Bevers6,
- John E. Doster7,
- Corrine Zarwan8,
- Laura Kruper9,
- Lori M. Minasian10,
- Leslie Ford10,
- Banu Arun6,
- Marian Neuhouser2,
- Gary E. Goodman11, and
- Powel H. Brown6
- 1Columbia University Irving Medical Center, New York, New York.
- 2Fred Hutchinson Cancer Research Center, Seattle, Washington.
- 3SWOG Statistics and Data Management Center, Seattle, Washington.
- 4William Beaumont Hospital, Beaumont NCORP, Troy, Michigan.
- 5Cancer Care Specialists of Central Illinois, Heartland NCORP, Decatur, Illinois.
- 6University of Texas, MD Anderson Cancer Center, Houston, Texas.
- 7Anderson Area Cancer Center, Southeast Clinical Oncology Research (SCOR) Consortium NCORP, Anderson, South Carolina.
- 8Lahey Hospital and Medical Center, Burlington, Massachusetts.
- 9City of Hope Medical Center, Duarte, California.
- 10Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
- 11Swedish Cancer Institute, Pacific Cancer Research Consortium NCORP, Seattle, Washington.
- ↵*Corresponding Author:
Katherine D. Crew, Columbia University Irving Medical Center, 161 Fort Washington Avenue, 10-1072, New York, NY 10032. Phone: 212-305-1732; Fax: 212-305-0178; E-mail: kd59{at}cumc.columbia.edu
Published OnlineFirst June 18, 2019
doi: 10.1158/1940-6207.CAPR-18-0444
Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)
Jump to section
Advertisement